Corcept Therap
1 products tracked · names used in filings: Corcept Therap
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Wed 25 Mar 2026🇺🇸 FDA approval
FDA approves Lifyorli (Copackaged) (relacorilant), a new medicine
Corcept Therap; NDA220641; New molecular entity; capsule · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Lifyorli (Copackaged) relacorilant | Approved | 2026-03-25 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.